Filter
112
Filtered Results: 112
Text search:
anti-interleukin
Featured
Recommendations
18
New Publications
11
Language
Document type
No document type
43
Guidelines
28
Studies & Reports
24
Manuals
10
Strategic & Response Plan
3
Fact sheets
2
Training Material
1
Situation Updates
1
Countries / Regions
India
8
Global
6
Brazil
6
Germany
5
Kenya
2
Philippines
2
South Africa
2
Uganda
2
Indonesia
2
El Salvador
1
Syria
1
Nigeria
1
Qatar
1
Mozambique
1
Africa
1
Venezuela
1
Latin America and the Carribbean
1
West and Central Africa
1
South–East Asia Region
1
Western and Central Europe
1
Portugal
1
East and Southern Africa
1
Bolivia
1
Bangladesh
1
Russia
1
Yemen
1
Angola
1
Zambia
1
South Sudan
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
33
Clinical Guidelines
12
Public Health
11
Women & Child Health
4
Pharmacy & Technologies
2
Key Resources
1
Toolboxes
COVID-19
33
HIV
9
NCDs
9
TB
8
Planetary Health
6
Mental Health
5
NTDs
5
Refugee
3
Ebola
3
Pharmacy
3
Conflict
3
Specific Hazards
2
Global Health Education
2
Rapid Response
1
Cholera
1
AMR
1
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is ...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
Änderung gegenüber der Version vom 26.1.2021: Aktualisierung der Informationen über monoklonale Antikörper und Rekonvaleszentenplasma
5 May 2021
This Information Note is intended to assist national TB programmes and health personnel worldwide to maintain essential tuberculosis (TB) services during the COVID-19 pandemic and in the recovery phase. It is important that recent progress made in TB prevention and care is not reversed b...
Nature Medicine, https://doi.org/10.1038/s41591-021-01283-z
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
With this quick reference guide, providers can easily recognize diseases and side effects related to climate change, implement appropriate management and provide guidance to exposed populations, provide up-to-date information on the relationship between the adverse effects of certain drugs and the w...
Con esta guía de referencia rápida podrán reconocer con facilidad las enfermedades y efectos secundarios relacionados con el cambio climático, administrar los tratamientos adecuados y aconsejar a las poblaciones expuestas, presentar información actualizada sobre la relación entre los efectos s...
COVID - 19 and PREGNANCY
Management guidelines for SARS-CoV-2 infection
Traitements contre la maladie à virus Ebola
recommended
Cette première version des orientations evolutives relatives a la prise en charge clinique de la MVE contient quatre nouvelles recommandations concernant l’utilisation de traitements contre la MVE, y compris deux recommandations fortes en faveur de l’utilisation de thérapies à base d’antico...
